文献速递湿疹皮炎与荨麻疹

患者报告结局测量信息系统整体健康量表在成人特应性皮炎中的效度与信度

Validity and reliability of Patient-Reported Outcomes Measurement Information System Global Health scale in adults with atopic dermatitis.
PubMed 文献 · J Am Acad Dermatol · 2021-01-20

本研究为皮肤科门诊前瞻性研究,纳入994例18-97岁成人特应性皮炎患者,评估PGH量表的测量性能。PGH身心4条目及2条目T分与多种皮炎、瘙痒、睡眠及生活质量指标呈中度至强相关,无地板/天花板效应,反应度尚可,重测信度良好。结论认为PGH评分在特应性皮炎中具有足够的效度与信度。

要点

  • PGH可用于评估成人特应性皮炎患者的健康相关生活质量。
  • PGH与DLQI在区分自报整体严重度方面均表现较差。
  • PGH无地板/天花板效应,条目无人口学差异功能。

核心结论

  • PGH评分在成人特应性皮炎中具有足够的效度与信度,可用于评估健康相关生活质量。

研究设计与样本

  • 前瞻性皮肤科门诊研究,纳入994例18-97岁特应性皮炎患者,评估PGH的测量性能。

主要发现

  • PGH身心4条目及2条目T分与映射Eq-5D评分彼此呈强至很强相关。
  • PGH与PO-SCORAD、PHQ-9、PROMIS睡眠障碍及相关损害、EASI、客观SCORAD呈中度至强Spearman相关。
  • PGH与POEM、最痒及平均瘙痒数字评分、SCORAD呈弱至中度相关。
  • DLQI与POEM、PO-SCORAD、瘙痒数字评分、EASI、SCORAD相关更强,与PHQ-9及PROMIS睡眠相关更弱。
  • PGH与DLQI区分自报整体严重度能力均较差,无地板/天花板效应,条目无人口学差异功能,反应度尚可至良好,重测信度均良好。

临床怎么用

  • 在成人特应性皮炎临床评估中可采用PGH量表评估健康相关生活质量。
  • 解读PGH时应结合皮炎严重度、瘙痒及睡眠等指标综合判断。
  • PGH不宜单独用于区分患者自报的整体疾病严重度分层。

局限性

  • 单中心研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patient-Reported Outcomes Measurement Information System Global Health (PGH) was validated to assess health-related quality of life in several diseases. Little is known about its measurement properties in adult atopic dermatitis. OBJECTIVE: Examine the measurement properties of PGH in adult atopic dermatitis. METHODS: A prospective dermatology practice-based study of 994 atopic dermatitis patients (18-97 years). RESULTS: PGH physical and mental health 4-item and abridged 2-item T scores, as well as mapped EuroQol-5D score, showed strong to very strong correlation with one another and moderate to strong Spearman correlations with Patient-Oriented Scoring Atopic Dermatitis, Patient-Health Questionnaire-9, Patient-Reported Outcomes Measurement Information System sleep disturbance and related impairment, Eczema Area and Severity Index, objective Scoring Atopic Dermatitis; and weak to moderate correlations with Patient Oriented Eczema Measure, numeric rating scale worst itch and average itch, and Scoring Atopic Dermatitis. The Dermatology Life Quality Index (DLQI) had stronger correlations with Patient Oriented Eczema Measure, Patient-Oriented Scoring Atopic Dermatitis, numeric rating scale worst itch and average itch, Eczema Area and Severity Index, and Scoring Atopic Dermatitis, but weaker correlations with Patient-Health Questionnaire-9 and Patient-Reported Outcomes Measurement Information System sleep disturbance and related impairment (convergent/divergent validity). PGH and DLQI scores had similarly poor ability to differentiate between levels of self-reported global atopic dermatitis severity (known-groups validity). No floor or ceiling effects were observed. No PGH or DLQI items had differential item functioning by demographics. PGH and DLQI scores showed fair to good responsiveness. Finally, PGH and DLQI showed similarly good test-retest reliability. LIMITATIONS: Single-center study. CONCLUSION: PGH scores had sufficient validity and reliability to assess health-related quality of life in atopic dermatitis.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Schwartzman G, Lei D, Yousaf M, et al. Validity and reliability of Patient-Reported Outcomes Measurement Information System Global Health scale in adults with atopic dermatitis. J Am Acad Dermatol. 2021. PMID: 33484762. doi:10.1016/j.jaad.2021.01.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。